2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene

Catalog No. :
ACPCSG357
CAS No. :
688756-58-3
Molecular Formula :
C28H32B2O4
Molecular Weight :
454.18

IUPAC Name:2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$111.00Login to see priceIn stockIn stock
5g98%$418.00Login to see priceIn stockIn stock
25g98%$1459.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene
IUPAC Name2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrene
MDL No.MFCD15143601
Molecular FormulaC28H32B2O4
Molecular Weight454.18
SMILESCC1(C)C(C)(C)OB(C2=CC3=CC=C4C=C(B5OC(C)(C)C(C)(C)O5)C=C(C4=C36)C=CC6=C2)O1
InChI KeyOSXGWTSPWMDJLH-UHFFFAOYSA-N
Synonym['Pyrene-2,7-diboronic Acid Bis(pinacol) Ester']
CAS No.688756-58-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPCSG357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCSG357 route product structure diagram
    ACPCSG357688756-58-3 In Stock
Inquiry

2. ACPCSG357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCSG357 route product structure diagram
    ACPCSG357688756-58-3 In Stock
Inquiry

Comments (0)